Johnson & Johnson vs. Spyre Therapeutics, Inc. Common Stock
Johnson & Johnson and Spyre Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | SYRE | |
|---|---|---|
| Market Cap | $599.12 billion | $7.52 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | SYRE | |
|---|---|---|
| Dividend Yield | 2.16% | — |
JNJ and SYRE split the dividend factors evenly.
Risk & Sentiment
| JNJ | SYRE | |
|---|---|---|
| Short Interest | 0.67% | 0.20% |
SYRE leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SYRE overview, SYRE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.